Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly-Reference-Cited by-同舟云学术

Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly

Published:2006-07 Issue:7 Volume:30 Page:849-858
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Gandhi Anita K.,Kang Jian,Naziruddin Syedah,Parton Anastasia,Schafer Peter H.,Stirling David I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference43 articles.

1. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha;Corral;J Immunol,1999

2. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway;LeBlanc;Blood,2004

3. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs;Schafer;J Pharmacol Exp Ther,2003

4. Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro;Haslett;J Infect Dis,2003

5. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma;Davies;Blood,2001

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced CC Chemokine Receptor 4 Expression in Tumor Cells after Lenalidomide Treatment for Adult T-Cell Leukemia/Lymphoma: A Case Report;Case Reports in Oncology;2024-05-30

2. Lenalidomide in the treatment of anti‐myelin‐associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose;European Journal of Neurology;2023-11-28

3. Efficacy and Safety Profile of Lenalidomide vs Lenalidomide + R-CHOP in patients with Diffuse Large B Cell Lymphoma: A Systematic Review;Pakistan Journal of Health Sciences;2023-08-31

4. Reduced CC chemokine receptor 4 expression after lenalidomide treatment for adult T-cell leukemia/lymphoma: a case report;2023-07-13

5. Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells;Melanoma Research;2023-07-12